Cascara Ventures is the new investment fund of Adriaan Hart de Ruijter, experienced entrepreneur and investor in life sciences. Founded in 2016, Cascara invests in the seed stage of companies that apply technology to prevention, therapy and research. Examples are vaccines, medical devices, pharmaceuticals, imaging, software, medical data, robotics, healthcare services, diagnostics and cell therapy.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Brussels, Be
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.cascaraventures.com
- Keywords
- Pharmaceutical Medicine, Cardiology, Oncology, Neurosurgery, Surgery, Surgical Navigation, Health Economics, Diabetes, Allergy, Immune Therapy, Interventional Cardiology, Orthopedic Surgery, Pain, Stroke, Heart Failure, Neurology, Venture Capital.
- HQ
- Brussels
Cascara Ventures Questions
Cascara Ventures's website is http://www.cascaraventures.com
Cascara Ventures's LinkedIn profile is https://be.linkedin.com/company/cascaraventures
Cascara Ventures has
3 employees.
View email and phone details for 3
employees at Cascara Ventures.
Cascara Ventures's industry is
Venture Capital and Private Equity Principals
Cascara Ventures's top competitors are
Surgify Medical Oy,
Ascend Capital Partners,
Capital-E Ii,
Fostec Ventures Gmbh,
Mte - Medtech Entrepreneurs,
Aurora Science Society,
Brightlands Venture Partners,
Ascend Capital Partners,
Avante Global Trade,
Mediventures Gmbh.
Cascara Ventures's categories are Venture Capital and Private Equity Principals
Cascara Ventures's founding year is 2016
